RHOBTB2突变扩展儿童交替性偏瘫表型谱
该研究通过运动障碍门诊及国际协作识别11例RHOBTB2相关疾病患者,回顾性分析其临床特征。所有患者携带外显子9的杂合错义变异(9例为新发),均表现为复杂运动障碍,其中8例出现偏瘫发作,提示RHOBTB2突变可致类似儿童交替性偏瘫(AHC)的表型。
要点
- RHOBTB2外显子9杂合错义变异可致复杂多形性运动障碍伴阵发性成分,类似AHC。
- RHOBTB2相关偏瘫发作出现较晚,报告自20月龄起,不同于经典ATP1A3相关AHC。
- 对AHC样表型且ATP1A3突变阴性者,应考虑检测RHOBTB2。
核心结论
- RHOBTB2杂合突变所致临床表型比早期婴儿癫痫性脑病64型更广,包括类似AHC的复杂多形性运动障碍伴阵发性成分。
- 对AHC样表型尤其ATP1A3突变阴性患者,应考虑行RHOBTB2检测。
研究设计与样本
- 通过专科儿科中心运动障碍门诊识别RHOBTB2相关疾病个体,并经国际合作补充病例。
- 采用回顾性病历复习获取临床资料,共报告11例受累个体。
主要发现
- 11例均携带涉及RHOBTB2外显子9的杂合错义变异,其中9例确认为新发。
- 所有患者均有复杂运动表型,包括至少2种不同类型的运动障碍,例如共济失调和肌张力障碍。
- 10例有含阵发性成分的运动障碍,8例经历偏瘫发作;这些事件报告较晚,仅见于20月龄起的RHOBTB2突变阳性患者。
- 7例患癫痫,其中4例达到无发作;所有患者均有智力障碍,通常为中重度。
- 4例出现明显肤色改变发作,4例有胃肠道症状。
关键数值与推荐
- 11例均携带RHOBTB2外显子9杂合错义变异,9例确认为新发。
- 10例有含阵发性成分的运动障碍,8例有偏瘫发作,偏瘫发作报告自20月龄起。
- 7例患癫痫,其中4例达到无发作;所有患者均有智力障碍,通常为中重度。
- 4例有肤色明显改变发作,4例有胃肠道症状。
临床怎么用
- 对表现为AHC样表型、尤其ATP1A3突变阴性的患者,应考虑检测RHOBTB2。
- 认识RHOBTB2相关运动障碍的阵发性成分与偏瘫发作,有助于与经典AHC鉴别。
- 评估RHOBTB2相关疾病时需关注癫痫、智力障碍、肤色改变及胃肠道症状等表现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the phenotypic spectrum of RHOBTB2-related disorders and specifically to determine whether patients fulfill criteria for alternating hemiplegia of childhood (AHC), we report the clinical features of 11 affected individuals. METHODS: Individuals with RHOBTB2-related disorders were identified through a movement disorder clinic at a specialist pediatric center, with additional cases identified through collaboration with other centers internationally. Clinical data were acquired through retrospective case-note review. RESULTS: Eleven affected patients were identified. All had heterozygous missense variants involving exon 9 of RHOBTB2, confirmed as de novo in 9 cases. All had a complex motor phenotype, including at least 2 different kinds of movement disorder, e.g., ataxia and dystonia. Many patients demonstrated several features fulfilling the criteria for AHC: 10 patients had a movement disorder including paroxysmal elements, and 8 experienced hemiplegic episodes. In contrast to classic AHC, commonly caused by mutations in ATP1A3, these events were reported later only in RHOBTB2 mutation-positive patients from 20 months of age. Seven patients had epilepsy, but of these, 4 patients achieved seizure freedom. All patients had intellectual disability, usually moderate to severe. Other features include episodes of marked skin color change and gastrointestinal symptoms, each in 4 patients. CONCLUSION: Although heterozygous RHOBTB2 mutations were originally described in early infantile epileptic encephalopathy type 64, our study confirms that they account for a more expansive clinical phenotype, including a complex polymorphic movement disorder with paroxysmal elements resembling AHC. RHOBTB2 testing should therefore be considered in patients with an AHC-like phenotype, particularly those negative for ATPA1A3 mutations.
引用
- Zagaglia S, Steel D, Krithika S, et al. RHOBTB2 Mutations Expand the Phenotypic Spectrum of Alternating Hemiplegia of Childhood. Neurology. 2021. PMID: 33504645. doi:10.1212/WNL.0000000000011543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。